Jimcy Platholi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jimcy Platholi has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Hugh Carroll Hemmings
Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA
5 shared publications Kenneth W. Johnson
Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA
4 shared publicationsJiaxin Xiang
Weill Cornell
3 shared publications- Karl F. Herold
Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA
3 shared publications Francis S. Lee
Department of Pharmacology, Weill Cornell Medicine
2 shared publicationsHugh C. Hemmings
Weill Cornell Medicine
2 shared publications
Latest Publications
- 11 November 2026
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (45)
From Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics
Rapid-acting antidepressants have challenged the long-standing view that therapeutic improvement in major depressive disorder requires chronic treatment with monoaminergic agents. Ketamine and classical psychedelics act through distinct proximal targets, yet both can produce rapid and persistent behavioral effects that implicate synaptic and circuit plasticity as the core mechanisms of antidepressant action. This review, based on a minisymposium presented at the 2026 Society for Neuroscience meeting, examines how brief pharmacological perturbations translate into lasting changes in mood-related networks. We first discuss hippocampal mechanisms underlying ketamine action, which include brain-derived neurotrophic factor (BDNF)/tropomyosin receptor kinase B (TrkB)-dependent homeostatic potentiation, TrkB cross talk with metabotropic glutamate receptor 5 (mGluR5) at CA3?CA1 synapses, extracellular signal-regulated kinase (ERK)-dual-specificity phosphatase 6 (DUSP6)-mediated extension of synaptic metaplasticity, and BDNF release at mossy fiber synapses and dentate gyrus neuronal maturation. We then consider how these local plasticity mechanisms interface with distributed circuits that regulate motivation, stress coping, and reward. Across brain regions, emerging work highlights the importance of cell type- and region-specific mechanisms that mediate ketamine's therapeutic actions. We expand on local prefrontal cortical inhibitory cellular signaling dynamics, including the interplay of various G-protein-coupled receptors (GPCRs) in cortical somatostatin interneurons and input-specific adaptations in accumbal circuits. Finally, we compare ketamine with psilocybin, an emerging therapeutic classic psychedelic for treatment-resistant depression that targets the 5-hydroxytryptamine 2A (5-HT2A) receptor primarily. A recurring theme is that an interplay of GPCRs can help shape the timing, localization, and persistence of ketamine-induced neuroplasticity. Together, these studies suggest that antidepressant efficacy arises not from a single pathway or brain region but from coordinated, temporally staged plasticity across molecules, synapses, cells, and circuits.
- 11 November 2026
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (45)
From Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics
Rapid-acting antidepressants have challenged the long-standing view that therapeutic improvement in major depressive disorder requires chronic treatment with monoaminergic agents. Ketamine and classical psychedelics act through distinct proximal targets, yet both can produce rapid and persistent behavioral effects that implicate synaptic and circuit plasticity as the core mechanisms of antidepressant action. This review, based on a minisymposium presented at the 2026 Society for Neuroscience meeting, examines how brief pharmacological perturbations translate into lasting changes in mood-related networks. We first discuss hippocampal mechanisms underlying ketamine action, which include brain-derived neurotrophic factor (BDNF)/tropomyosin receptor kinase B (TrkB)-dependent homeostatic potentiation, TrkB cross talk with metabotropic glutamate receptor 5 (mGluR5) at CA3?CA1 synapses, extracellular signal-regulated kinase (ERK)-dual-specificity phosphatase 6 (DUSP6)-mediated extension of synaptic metaplasticity, and BDNF release at mossy fiber synapses and dentate gyrus neuronal maturation. We then consider how these local plasticity mechanisms interface with distributed circuits that regulate motivation, stress coping, and reward. Across brain regions, emerging work highlights the importance of cell type- and region-specific mechanisms that mediate ketamine's therapeutic actions. We expand on local prefrontal cortical inhibitory cellular signaling dynamics, including the interplay of various G-protein-coupled receptors (GPCRs) in cortical somatostatin interneurons and input-specific adaptations in accumbal circuits. Finally, we compare ketamine with psilocybin, an emerging therapeutic classic psychedelic for treatment-resistant depression that targets the 5-hydroxytryptamine 2A (5-HT2A) receptor primarily. A recurring theme is that an interplay of GPCRs can help shape the timing, localization, and persistence of ketamine-induced neuroplasticity. Together, these studies suggest that antidepressant efficacy arises not from a single pathway or brain region but from coordinated, temporally staged plasticity across molecules, synapses, cells, and circuits.
- Open Access
Increased expression of developmental Nav1.3 promotes hippocampal CA3 hyperexcitability in early-stage 5xFAD mice
Neuronal hyperexcitability is an early and pervasive feature of Alzheimers disease (AD) that both predicts and accelerates subsequent cognitive decline. Persistent excitability depends on activation of voltage-gated sodium channels (Nav), yet most work has focused on the Nav subtypes expressed in the mature brain. Here, we show that Nav1.3, a subtype normally confined to early development, shows aberrantly increased expression in the dentate gyrus (DG)-CA3 circuit in early-stage 5xFAD mice. Using in vivo fiber photometry, three-month-old 5xFAD mice exhibited greater CA3 neuron population activity than seven-month-old 5xFAD mice or wildtype littermates. Oligomeric Aβ expression, assessed by immunolabeling, was sparse at three months and rose significantly by seven months, indicating that CA3 hyperactivity emerges before substantial oligomeric Aβ accumulates. This early activity increase coincided with elevated Nav1.3 expression at the DG-CA3 mossy fiber synapse, localized by immuno-electron microscopy to presynaptic mossy fiber terminals, where it exceeded levels in age-matched controls. Lentiviral shRNA-mediated knockdown of Nav1.3 expression in CA3 normalized CA3 network activity in early-stage 5xFAD mice. These findings identify Nav1.3 expression at DG-CA3 mossy fiber synapses as a driver of early hippocampal network dysfunction in AD and suggest Nav1.3 modulation as a potential target for circuit-level intervention.
Open AccessIncreased expression of developmental Nav1.3 promotes hippocampal CA3 hyperexcitability in early-stage 5xFAD mice
Neuronal hyperexcitability is an early and pervasive feature of Alzheimers disease (AD) that both predicts and accelerates subsequent cognitive decline. Persistent excitability depends on activation of voltage-gated sodium channels (Nav), yet most work has focused on the Nav subtypes expressed in the mature brain. Here, we show that Nav1.3, a subtype normally confined to early development, shows aberrantly increased expression in the dentate gyrus (DG)-CA3 circuit in early-stage 5xFAD mice. Using in vivo fiber photometry, three-month-old 5xFAD mice exhibited greater CA3 neuron population activity than seven-month-old 5xFAD mice or wildtype littermates. Oligomeric Aβ expression, assessed by immunolabeling, was sparse at three months and rose significantly by seven months, indicating that CA3 hyperactivity emerges before substantial oligomeric Aβ accumulates. This early activity increase coincided with elevated Nav1.3 expression at the DG-CA3 mossy fiber synapse, localized by immuno-electron microscopy to presynaptic mossy fiber terminals, where it exceeded levels in age-matched controls. Lentiviral shRNA-mediated knockdown of Nav1.3 expression in CA3 normalized CA3 network activity in early-stage 5xFAD mice. These findings identify Nav1.3 expression at DG-CA3 mossy fiber synapses as a driver of early hippocampal network dysfunction in AD and suggest Nav1.3 modulation as a potential target for circuit-level intervention.
- Open Access
Fast-acting antidepressants trigger presynaptic BDNF release and structural plasticity at mouse mossy fiber-CA3 synapses
Major depressive disorder is associated with deficits in hippocampal synaptic plasticity that depend on brain-derived neurotrophic factor (BDNF) release from both axonal and dendritic compartments. Antidepressant efficacy requires enhanced BDNF signaling, thought to be mediated by drug-induced BDNF release from postsynaptic dendritic spines. Here, we show that fast-acting antidepressants rapidly trigger BDNF secretion from presynaptic terminals in hippocampal area CA3. At antidepressant-relevant concentrations, ketamine and its metabolite (2R,6R)-hydroxynorketamine (HNK) induced BDNF release within minutes from mossy fiber terminals of dentate granule neurons in rat hippocampal cultures, with no detectable secretion from dendritic spines. This antidepressant-evoked BDNF release required presynaptic NMDA receptors (preNMDARs). Conditional genetic deletion of preNMDARs from granule neurons abolished ketamine- and HNK-induced BDNF exocytosis in acute mouse hippocampal slices, establishing a presynaptic receptor mechanism for antidepressant-induced neurotrophin release. In CA3 pyramidal neurons that receive mossy fiber input, both compounds induced rapid remodeling of dendritic spines, resulting in increased spine density. Together, these findings identify presynaptic terminals as a previously unrecognized source of antidepressant-evoked BDNF release and establish a new cellular mechanism for the rapid synaptic effects of fast-acting antidepressants.
Open AccessFast-acting antidepressants trigger presynaptic BDNF release and structural plasticity at mouse mossy fiber-CA3 synapses
Major depressive disorder is associated with deficits in hippocampal synaptic plasticity that depend on brain-derived neurotrophic factor (BDNF) release from both axonal and dendritic compartments. Antidepressant efficacy requires enhanced BDNF signaling, thought to be mediated by drug-induced BDNF release from postsynaptic dendritic spines. Here, we show that fast-acting antidepressants rapidly trigger BDNF secretion from presynaptic terminals in hippocampal area CA3. At antidepressant-relevant concentrations, ketamine and its metabolite (2R,6R)-hydroxynorketamine (HNK) induced BDNF release within minutes from mossy fiber terminals of dentate granule neurons in rat hippocampal cultures, with no detectable secretion from dendritic spines. This antidepressant-evoked BDNF release required presynaptic NMDA receptors (preNMDARs). Conditional genetic deletion of preNMDARs from granule neurons abolished ketamine- and HNK-induced BDNF exocytosis in acute mouse hippocampal slices, establishing a presynaptic receptor mechanism for antidepressant-induced neurotrophin release. In CA3 pyramidal neurons that receive mossy fiber input, both compounds induced rapid remodeling of dendritic spines, resulting in increased spine density. Together, these findings identify presynaptic terminals as a previously unrecognized source of antidepressant-evoked BDNF release and establish a new cellular mechanism for the rapid synaptic effects of fast-acting antidepressants.
- Open Access
- 19 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Sevoflurane inhibition of the developmentally expressed neuronal sodium channel Nav1.3
Neuronal voltage-gated sodium channels (Nav) are major targets for the neurophysiological actions of general anesthetics. In the adult brain, cell type-specific effects on synaptic transmission are attributed to the differential sensitivity to volatile anesthetics of specific Nav subtypes preferentially expressed in mature neurons (Nav1.1, Nav1.2, Nav1.6). Comparatively, developing neurons are more excitable than mature neurons. We determined volatile anesthetic effects on Na+ currents mediated by Nav1.3, the principal Nav subtype expressed in developing neurons. Sevoflurane at clinical concentrations inhibited peak Na+ current of human Nav1.3 heterologously expressed in HEK293T cells in a voltage-dependent manner, induced a − 6.1 mV hyperpolarizing shift in the voltage dependence of steady-state inactivation, and slowed recovery from fast inactivation. Nav1.3-mediated Na+ currents also exhibited distinct activation properties associated with hyperexcitability, including prominent persistent currents and ramp currents, both of which were significantly reduced by sevoflurane. Nav1.3 showed a more depolarized voltage dependence of steady-state inactivation than Nav1.2, consistent with its higher propensity for sustained repetitive firing. Nav1.2 exhibited minimal persistent and ramp currents, and these were unaffected by sevoflurane. These findings identify subtype-specific effects of sevoflurane on neuronal Nav subtype electrophysiological properties, and suggest a mechanistic basis for increased anesthetic sensitivity and toxicity in early neuronal differentiation and maturation.
- 19 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Open AccessSevoflurane inhibition of the developmentally expressed neuronal sodium channel Nav1.3
Neuronal voltage-gated sodium channels (Nav) are major targets for the neurophysiological actions of general anesthetics. In the adult brain, cell type-specific effects on synaptic transmission are attributed to the differential sensitivity to volatile anesthetics of specific Nav subtypes preferentially expressed in mature neurons (Nav1.1, Nav1.2, Nav1.6). Comparatively, developing neurons are more excitable than mature neurons. We determined volatile anesthetic effects on Na+ currents mediated by Nav1.3, the principal Nav subtype expressed in developing neurons. Sevoflurane at clinical concentrations inhibited peak Na+ current of human Nav1.3 heterologously expressed in HEK293T cells in a voltage-dependent manner, induced a − 6.1 mV hyperpolarizing shift in the voltage dependence of steady-state inactivation, and slowed recovery from fast inactivation. Nav1.3-mediated Na+ currents also exhibited distinct activation properties associated with hyperexcitability, including prominent persistent currents and ramp currents, both of which were significantly reduced by sevoflurane. Nav1.3 showed a more depolarized voltage dependence of steady-state inactivation than Nav1.2, consistent with its higher propensity for sustained repetitive firing. Nav1.2 exhibited minimal persistent and ramp currents, and these were unaffected by sevoflurane. These findings identify subtype-specific effects of sevoflurane on neuronal Nav subtype electrophysiological properties, and suggest a mechanistic basis for increased anesthetic sensitivity and toxicity in early neuronal differentiation and maturation.
- Open Access
Sevoflurane inhibition of the developmentally expressed neuronal sodium channel Na v 1.3
Neuronal voltage-gated sodium channels (Na v ) are major targets for the neurophysiological actions of general anesthetics. In the adult brain, cell type-specific effects on synaptic transmission are attributed to the differential sensitivity to volatile anesthetics of specific Na v subtypes preferentially expressed in mature neurons (Na v 1.1, Na v 1.2, Na v 1.6). Compared to mature neurons, neurons in the developing CNS are more excitable. Since the subtype-selective effects of volatile anesthetics on Na v during early development are unknown, we determined volatile anesthetic effects on Na + currents mediated by Na v 1.3, the principal Na v subtype expressed in developing neurons. Sevoflurane at clinically relevant concentrations inhibited peak Na + current ( I Na ) of human Na v 1.3 heterologously expressed in HEK293T cells in a voltage- dependent manner, induced a −6.1 mV hyperpolarizing shift in the voltage dependence of steady- state inactivation, and slowed recovery from fast inactivation. Na v 1.3-mediated Na + currents also exhibited distinct activation properties associated with neuronal hyperexcitability, including prominent persistent currents and ramp currents, both of which were significantly reduced by sevoflurane. The major neuronal subtype Na v 1.2 showed a more hyperpolarized voltage dependence of steady-state inactivation than Na v 1.3. Consistent with its lower propensity for sustained repetitive firing, Na v 1.2 exhibited minimal persistent and ramp currents, and these were unaffected by sevoflurane. These findings identify subtype-specific effects of the volatile anesthetic sevoflurane on neuronal Na v subtypes and suggest a mechanistic basis for increased anesthetic sensitivity in early neuronal differentiation and maturation.
Open AccessSevoflurane inhibition of the developmentally expressed neuronal sodium channel Na v 1.3
Neuronal voltage-gated sodium channels (Na v ) are major targets for the neurophysiological actions of general anesthetics. In the adult brain, cell type-specific effects on synaptic transmission are attributed to the differential sensitivity to volatile anesthetics of specific Na v subtypes preferentially expressed in mature neurons (Na v 1.1, Na v 1.2, Na v 1.6). Compared to mature neurons, neurons in the developing CNS are more excitable. Since the subtype-selective effects of volatile anesthetics on Na v during early development are unknown, we determined volatile anesthetic effects on Na + currents mediated by Na v 1.3, the principal Na v subtype expressed in developing neurons. Sevoflurane at clinically relevant concentrations inhibited peak Na + current ( I Na ) of human Na v 1.3 heterologously expressed in HEK293T cells in a voltage- dependent manner, induced a −6.1 mV hyperpolarizing shift in the voltage dependence of steady- state inactivation, and slowed recovery from fast inactivation. Na v 1.3-mediated Na + currents also exhibited distinct activation properties associated with neuronal hyperexcitability, including prominent persistent currents and ramp currents, both of which were significantly reduced by sevoflurane. The major neuronal subtype Na v 1.2 showed a more hyperpolarized voltage dependence of steady-state inactivation than Na v 1.3. Consistent with its lower propensity for sustained repetitive firing, Na v 1.2 exhibited minimal persistent and ramp currents, and these were unaffected by sevoflurane. These findings identify subtype-specific effects of the volatile anesthetic sevoflurane on neuronal Na v subtypes and suggest a mechanistic basis for increased anesthetic sensitivity in early neuronal differentiation and maturation.
- Open Access
- 23 June 2022
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 927149
A Common Human Brain-Derived Neurotrophic Factor Polymorphism Leads to Prolonged Depression of Excitatory Synaptic Transmission by Isoflurane in Hippocampal Cultures
Multiple presynaptic and postsynaptic targets have been identified for the reversible neurophysiological effects of general anesthetics on synaptic transmission and neuronal excitability. However, the synaptic mechanisms involved in persistent depression of synaptic transmission resulting in more prolonged neurological dysfunction following anesthesia are less clear. Here, we show that brain-derived neurotrophic factor (BDNF), a growth factor implicated in synaptic plasticity and dysfunction, enhances glutamate synaptic vesicle exocytosis, and that attenuation of vesicular BDNF release by isoflurane contributes to transient depression of excitatory synaptic transmission in mice. This reduction in synaptic vesicle exocytosis by isoflurane was acutely irreversible in neurons that release less endogenous BDNF due to a polymorphism (BDNF Val66Met; rs6265) compared to neurons from wild-type mice. These effects were prevented by exogenous application of BDNF. Our findings identify a role for a common human BDNF single nucleotide polymorphism in persistent changes of synaptic function following isoflurane exposure. These short-term persistent alterations in excitatory synaptic transmission indicate a role for human genetic variation in anesthetic effects on synaptic plasticity and neurocognitive function.
- 23 June 2022
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 927149
Open AccessA Common Human Brain-Derived Neurotrophic Factor Polymorphism Leads to Prolonged Depression of Excitatory Synaptic Transmission by Isoflurane in Hippocampal Cultures
Multiple presynaptic and postsynaptic targets have been identified for the reversible neurophysiological effects of general anesthetics on synaptic transmission and neuronal excitability. However, the synaptic mechanisms involved in persistent depression of synaptic transmission resulting in more prolonged neurological dysfunction following anesthesia are less clear. Here, we show that brain-derived neurotrophic factor (BDNF), a growth factor implicated in synaptic plasticity and dysfunction, enhances glutamate synaptic vesicle exocytosis, and that attenuation of vesicular BDNF release by isoflurane contributes to transient depression of excitatory synaptic transmission in mice. This reduction in synaptic vesicle exocytosis by isoflurane was acutely irreversible in neurons that release less endogenous BDNF due to a polymorphism (BDNF Val66Met; rs6265) compared to neurons from wild-type mice. These effects were prevented by exogenous application of BDNF. Our findings identify a role for a common human BDNF single nucleotide polymorphism in persistent changes of synaptic function following isoflurane exposure. These short-term persistent alterations in excitatory synaptic transmission indicate a role for human genetic variation in anesthetic effects on synaptic plasticity and neurocognitive function.
- Open Access
A common human brain-derived neurotrophic factor polymorphism leads to sustained depression of excitatory synaptic transmission by isoflurane in hippocampus
Multiple presynaptic and postsynaptic targets have been identified for the reversible neurophysiological effects of general anesthetics on synaptic transmission and neuronal excitability. However, the synaptic mechanisms involved in persistent depression of synaptic transmission resulting in more prolonged neurological dysfunction following anesthesia are less clear. Here, we show that brain-derived neurotrophic factor (BDNF), a growth factor implicated in synaptic plasticity and dysfunction, enhances glutamate synaptic vesicle exocytosis, and that attenuation of vesicular BDNF release by isoflurane contributes to transient depression of excitatory synaptic transmission in mice. This reduction in synaptic vesicle exocytosis was irreversible in neurons that release less endogenous BDNF due to a polymorphism (BDNF Val66Met) compared to wild-type mouse hippocampal neurons following isoflurane exposure. These effects were prevented by exogenous application of BDNF. Our findings identify a role for a common human BDNF single nucleotide polymorphism (Val66Met; rs6265) in persistent changes of synaptic function following isoflurane exposure. These persistent alterations in excitatory synaptic transmission have important implications for the role of genotype in anesthetic effects on synaptic plasticity and neurocognitive function.
Open AccessA common human brain-derived neurotrophic factor polymorphism leads to sustained depression of excitatory synaptic transmission by isoflurane in hippocampus
Multiple presynaptic and postsynaptic targets have been identified for the reversible neurophysiological effects of general anesthetics on synaptic transmission and neuronal excitability. However, the synaptic mechanisms involved in persistent depression of synaptic transmission resulting in more prolonged neurological dysfunction following anesthesia are less clear. Here, we show that brain-derived neurotrophic factor (BDNF), a growth factor implicated in synaptic plasticity and dysfunction, enhances glutamate synaptic vesicle exocytosis, and that attenuation of vesicular BDNF release by isoflurane contributes to transient depression of excitatory synaptic transmission in mice. This reduction in synaptic vesicle exocytosis was irreversible in neurons that release less endogenous BDNF due to a polymorphism (BDNF Val66Met) compared to wild-type mouse hippocampal neurons following isoflurane exposure. These effects were prevented by exogenous application of BDNF. Our findings identify a role for a common human BDNF single nucleotide polymorphism (Val66Met; rs6265) in persistent changes of synaptic function following isoflurane exposure. These persistent alterations in excitatory synaptic transmission have important implications for the role of genotype in anesthetic effects on synaptic plasticity and neurocognitive function.
- 31 July 2017
- Published by Wiley in Journal of Comparative Neurology
- Vol. 525 (16) , 3563-3578
Sodium channel subtypes are differentially localized to pre‐ and post‐synaptic sites in rat hippocampus
Voltage‐gated Na+ channels (Nav) modulate neuronal excitability, but the roles of the various Nav subtypes in specific neuronal functions such as synaptic transmission are unclear. We investigated expression of the three major brain Nav subtypes (Nav1.1, Nav1.2, Nav1.6) in area CA1 and dentate gyrus of rat hippocampus. Using light and electron microscopy, we found labeling for all three Nav subtypes on dendrites, dendritic spines, and axon terminals, but the proportion of pre‐ and post‐synaptic labeling for each subtype varied within and between subregions of CA1 and dentate gyrus. In the central hilus (CH) of the dentate gyrus, Nav1.1 immunoreactivity was selectively expressed in presynaptic profiles, while Nav1.2 and Nav1.6 were expressed both pre‐ and post‐synaptically. In contrast, in the stratum radiatum (SR) of CA1, Nav1.1, Nav1.2, and Nav1.6 were selectively expressed in postsynaptic profiles. We next compared differences in Nav subtype expression between CH and SR axon terminals and between CH and SR dendrites and spines. Nav1.1 and Nav1.2 immunoreactivity was preferentially localized to CH axon terminals compared to SR, and in SR dendrites and spines compared to CH. No differences in Nav1.6 immunoreactivity were found between axon terminals of CH and SR or between dendrites and spines of CH and SR. All Nav subtypes in both CH and SR were preferentially associated with asymmetric synapses rather than symmetric synapses. These findings indicate selective presynaptic and postsynaptic Nav expression in glutamatergic synapses of CH and SR supporting neurotransmitter release and synaptic plasticity.
- 31 July 2017
- Published by Wiley in Journal of Comparative Neurology
- Vol. 525 (16) , 3563-3578
Sodium channel subtypes are differentially localized to pre‐ and post‐synaptic sites in rat hippocampus
Voltage‐gated Na+ channels (Nav) modulate neuronal excitability, but the roles of the various Nav subtypes in specific neuronal functions such as synaptic transmission are unclear. We investigated expression of the three major brain Nav subtypes (Nav1.1, Nav1.2, Nav1.6) in area CA1 and dentate gyrus of rat hippocampus. Using light and electron microscopy, we found labeling for all three Nav subtypes on dendrites, dendritic spines, and axon terminals, but the proportion of pre‐ and post‐synaptic labeling for each subtype varied within and between subregions of CA1 and dentate gyrus. In the central hilus (CH) of the dentate gyrus, Nav1.1 immunoreactivity was selectively expressed in presynaptic profiles, while Nav1.2 and Nav1.6 were expressed both pre‐ and post‐synaptically. In contrast, in the stratum radiatum (SR) of CA1, Nav1.1, Nav1.2, and Nav1.6 were selectively expressed in postsynaptic profiles. We next compared differences in Nav subtype expression between CH and SR axon terminals and between CH and SR dendrites and spines. Nav1.1 and Nav1.2 immunoreactivity was preferentially localized to CH axon terminals compared to SR, and in SR dendrites and spines compared to CH. No differences in Nav1.6 immunoreactivity were found between axon terminals of CH and SR or between dendrites and spines of CH and SR. All Nav subtypes in both CH and SR were preferentially associated with asymmetric synapses rather than symmetric synapses. These findings indicate selective presynaptic and postsynaptic Nav expression in glutamatergic synapses of CH and SR supporting neurotransmitter release and synaptic plasticity.